Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome.

Cassius, Charles; Le Buanec, Hélène; Bouaziz, Jean-David; Amode, Reyhan

doi:10.1155/2019/9141420

Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome.

Cassius, Charles

;

Le Buanec, Hélène

;

Bouaziz, Jean-David

;

Amode, Reyhan

(2019) Journal of Immunology Research — Vol. 2019, p. 9141420 [1-16] (2019)

Files

CassiusCJImmunolRes2019.pdf

Open Access
Adobe PDF
1.61 MB

Download

Details

Authors

Cassius, CharlesUCLouvain
Author
Le Buanec, Hélène
Author
Bouaziz, Jean-David
Author
Amode, Reyhan
Author

Abstract

Dermatomyositis pathophysiology is complex. In recent years, medical research has identified molecules associated with disease activity. Besides providing insights into the driving mechanisms of dermatomyositis, these findings could provide potential biomarkers. Activity markers can be used to monitor disease activity in clinical trials and may also be useful in daily practice. This article reviews molecules that could be used as biomarkers for diagnosis and monitoring dermatomyositis disease activity.

Affiliations

Citations

APA
Chicago
FWB

Cassius, C., Le Buanec, H., Bouaziz, J.-D., & Amode, R. (2019). Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome. Journal of Immunology Research, 2019, 9141420 [1-16]. https://doi.org/10.1155/2019/9141420 (Original work published 2019)